Nordea Investment Management AB Has $6.52 Million Stake in HealthEquity, Inc. $HQY

Nordea Investment Management AB lifted its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY) by 15.2% in the 3rd quarter, HoldingsChannel.com reports. The fund owned 68,790 shares of the company’s stock after purchasing an additional 9,058 shares during the quarter. Nordea Investment Management AB’s holdings in HealthEquity were worth $6,515,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also added to or reduced their stakes in the business. Norges Bank bought a new position in HealthEquity during the second quarter worth $75,072,000. Westfield Capital Management Co. LP boosted its holdings in shares of HealthEquity by 124.6% during the 2nd quarter. Westfield Capital Management Co. LP now owns 1,265,208 shares of the company’s stock worth $132,543,000 after buying an additional 701,819 shares during the period. AQR Capital Management LLC grew its stake in HealthEquity by 148.5% in the 2nd quarter. AQR Capital Management LLC now owns 1,107,448 shares of the company’s stock valued at $116,016,000 after buying an additional 661,795 shares during the last quarter. Man Group plc raised its holdings in HealthEquity by 1,331.8% in the 2nd quarter. Man Group plc now owns 254,652 shares of the company’s stock valued at $26,677,000 after acquiring an additional 236,867 shares during the period. Finally, Viking Global Investors LP acquired a new stake in HealthEquity during the second quarter worth approximately $23,021,000. Institutional investors own 99.55% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on the company. Barrington Research reaffirmed an “outperform” rating and issued a $125.00 target price on shares of HealthEquity in a research report on Thursday, December 4th. Citigroup reaffirmed an “outperform” rating on shares of HealthEquity in a research report on Thursday, December 4th. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and issued a $120.00 price objective on shares of HealthEquity in a report on Friday, December 5th. BTIG Research reaffirmed a “buy” rating and set a $130.00 target price on shares of HealthEquity in a report on Thursday, December 4th. Finally, Citizens Jmp increased their target price on HealthEquity from $117.00 to $122.00 and gave the stock a “market outperform” rating in a report on Thursday, December 4th. Two analysts have rated the stock with a Strong Buy rating, twelve have issued a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $119.60.

Insiders Place Their Bets

In other HealthEquity news, EVP Delano Ladd sold 1,500 shares of the company’s stock in a transaction dated Friday, December 19th. The stock was sold at an average price of $94.72, for a total value of $142,080.00. Following the completion of the transaction, the executive vice president owned 73,979 shares of the company’s stock, valued at $7,007,290.88. This represents a 1.99% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Elimelech Rosner sold 10,959 shares of the stock in a transaction dated Thursday, December 18th. The shares were sold at an average price of $95.45, for a total value of $1,046,036.55. Following the completion of the transaction, the executive vice president owned 45,742 shares of the company’s stock, valued at $4,366,073.90. This represents a 19.33% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 15,459 shares of company stock worth $1,483,062 in the last 90 days. 1.50% of the stock is currently owned by corporate insiders.

HealthEquity Trading Down 1.8%

Shares of HealthEquity stock opened at $85.37 on Friday. The firm’s 50 day moving average is $96.16 and its 200 day moving average is $94.54. The firm has a market capitalization of $7.29 billion, a PE ratio of 39.16, a price-to-earnings-growth ratio of 1.23 and a beta of 0.20. HealthEquity, Inc. has a 1 year low of $74.07 and a 1 year high of $116.65. The company has a current ratio of 4.13, a quick ratio of 4.13 and a debt-to-equity ratio of 0.46.

HealthEquity (NASDAQ:HQY) last issued its earnings results on Wednesday, December 3rd. The company reported $1.01 earnings per share for the quarter, beating analysts’ consensus estimates of $0.90 by $0.11. The firm had revenue of $322.16 million for the quarter, compared to analyst estimates of $320.92 million. HealthEquity had a net margin of 14.86% and a return on equity of 12.94%. The company’s quarterly revenue was up 7.2% on a year-over-year basis. During the same quarter last year, the business posted $0.78 earnings per share. HealthEquity has set its FY 2026 guidance at 3.870-3.950 EPS. Equities research analysts forecast that HealthEquity, Inc. will post 2.32 earnings per share for the current fiscal year.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.